Gwendolyn Gresham - Dec 31, 2021 Form 4 Insider Report for CORE LABORATORIES N V (CLB)

Role
SVP
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Stock symbol
CLB
Transactions as of
Dec 31, 2021
Transactions value $
-$41,274
Form type
4
Date filed
1/4/2022, 04:53 PM
Previous filing
Jun 21, 2021
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Shares Tax liability -$41.3K -1.85K -19.2% $22.31* 7.78K Dec 31, 2021 Direct
transaction CLB Common Shares Options Exercise $0 +4.7K +95.28% $0.00 9.63K Dec 31, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Performance Shares Options Exercise $0 -4.7K -100% $0.00* 0 Dec 31, 2021 Common Shares 4.7K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These awards vested at the end of a three-year performance period that began on January 1, 2019 and ended December 31, 2021 (the "Performance Period"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period.